Recent Patents on CNS Drug Discovery (Discontinued)
Title:Acknowledgements to Reviewers
Volume: 10 Issue: 2
Export Options
About this article
Cite this article as:
Acknowledgements to Reviewers, Recent Patents on CNS Drug Discovery (Discontinued) 2015; 10 (2) . https://dx.doi.org/10.2174/157488981002160919210209
DOI https://dx.doi.org/10.2174/157488981002160919210209 |
Print ISSN 1574-8898 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3954 |
28
Related Articles
-
Speech Recognition Using Elman Artificial Neural Network and Linear Predictive Coding
Recent Advances in Computer Science and Communications Tumor Targeted Therapies: Strategies for Killing Cancer but not Normal Cells
Current Cancer Therapy Reviews Review of Patents on Microneedle Applicators
Recent Patents on Drug Delivery & Formulation Involvement of the Transforming Growth Factor β in the Pathogenesis of Hereditary Hemorrhagic Telangiectasia
Current Pharmaceutical Design Estrogen Receptors alpha and beeta Two Receptors of a Kind
Current Medicinal Chemistry An Insight into the Therapeutic Potential of Major Coffee Components
Current Drug Metabolism Synthesis and Biological Evaluation of New imidazo[1,2-a]pyridine Derivatives as Selective COX-2 Inhibitors
Letters in Drug Design & Discovery The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Current and Under Development Treatment Modalities of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Connecting A Tumor to the Environment
Current Pharmaceutical Design Effects of Ranolazine on Cardiovascular System
Recent Patents on Cardiovascular Drug Discovery Modulation of Mast Cell and Basophil Functions by Benzene Metabolites
Current Pharmaceutical Design Tackling Alzheimer’s Disease with Existing Drugs: A Promising Strategy for Bypassing Obstacles
Current Medicinal Chemistry Molecular Manipulation Targeting Regulation of Dopaminergic Differentiation and Proliferation of Neural Stem Cells or Pluripotent Stem Cells
CNS & Neurological Disorders - Drug Targets Synthesis, Molecular Docking and In Vitro Antimicrobial Studies of New Hexahydroindazole Derivatives of Curcumin
Letters in Drug Design & Discovery Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics
Current Pharmaceutical Design Malnutrition in Patients with End-Stage Renal Disease - Anorexia,Cachexia and Catabolism
Current Nutrition & Food Science Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins
CNS & Neurological Disorders - Drug Targets Microvascular Endothelial Dysfunction in Obesity and Hypertension
Current Pharmaceutical Design Drug-Related Decrease in Neuropsychological Functions of Abstinent Drug Users
Current Drug Abuse Reviews